HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRN Sees Voluntary Supplement Registry Bringing Regulatory Plus Retail Benefits

This article was originally published in The Tan Sheet

Executive Summary

While an industry-run registry would not conduct pre-market evaluations nor state that a product’s health claims and ingredients are compliant, retailers and other businesses selling supplements could see it as a seal of approval.

You may also be interested in...



Sharfstein Suggests Requiring Supplements Registration, Testing Standards

Oversight authorized by DSHEA “is not the regulatory system for dietary supplements sold to the American public,” says former FDA official Joshua Sharfstein.

US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry

Industry trade groups say FDA decision against starting rulemaking for lawful use of hemp ingredients is not only overdue but failed to clear the air for businesses making or using the ingredients.

Is US Hemp Policy Heading For Farm Bill, Act III?

It could take next farm bill, on lawmakers’ 2023 to-do list, to extinguish inferno of disagreement between FDA and regulated industries over lawful use of hemp-based ingredients in supplements as well as food and non-drug topicals. Before 2018 bill de-scheduled hemp, 2014 bill expanded access to hemp for research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel